Effect of the dual 5α-reductase inhibitor, dutasteride, on serum testosterone and body mass index in men with benign prostatic hyperplasia

BJU International

Volumn 105, Issue 7, 2010, Pages 970-974

  Hong, Sung Kyu ^a   Min, Gyeong Eun ^a   Ha, Seung Bum ^a   Doo, Seung Hwan ^a   Kang, Min Yong ^a   Park, Hong Joo ^a   Yoon, Cheol Yong ^a   Jeong, Seong Jin ^a   Byun, Seok Soo ^a   Lee, Sang Eun ^a  

^a Seoul National University Bundang Hospital   (South Korea)

Author keywords

Body mass index; Dutasteride; Prostate; Prostatic hyperplasia; Testosterone

Indexed keywords

DUTASTERIDE; TAMSULOSIN; TESTOSTERONE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AZASTEROID; CHOLESTENONE 5ALPHA REDUCTASE; ENZYME INHIBITOR; SULFONAMIDE;

ADULT; AGED; ARTICLE; BODY MASS; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; TESTOSTERONE BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG ANTAGONISM; DRUG COMBINATION; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADRENERGIC ALPHA-ANTAGONISTS; AGED; AZASTEROIDS; BODY MASS INDEX; CHOLESTENONE 5 ALPHA-REDUCTASE; DRUG THERAPY, COMBINATION; ENZYME INHIBITORS; HUMANS; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; SULFONAMIDES; TESTOSTERONE; TREATMENT OUTCOME;

EID: 77749286509     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08915.x     Document Type: Article

References (15)

1. Roehrborn CG, Boyle P, Nickel JC et al. Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia. Urology 2002 60 : 434 441
2. McConnell JD, Bruskewitz R, Walsh PC et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Engl J Med 1998 338 : 557 563
3. Clark RV, Hermann DJ, Cunningham GR et al. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J Clin Endocrinol Metab 2004 89 : 2179 2184
4. Rittmaster RS, Lemay A, Zwicker H et al. Effect of finasteride, a 5 alpha-reductase inhibitor, on serum gonadotropins in normal men. J Clin Endocrinol Metab 1992 75 : 484 488
5. Kaufman KD, Olsen EA, Whiting D et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol 1998 39 : 578 589
6. Roehrborn CG, Lee M, Meehan A, Waldstreicher J, the PLESS Study Group. Effects of finasteride on serum testosterone and body mass index in men with benign prostatic hyperplasia. Urology 2003 62 : 894 899
7. Andriole G, Bruchovsky N, Chung LW et al. Dihydrotestosterone and the prostate: the scientific rationale for 5alpha-reductase inhibitors in the treatment of benign prostatic hyperplasia. J Urol 2004 172 : 1399 1403
8. Rittmaster R, Hahn RG, Ray P, Shannon JB, Wurzel R. Effect of dutasteride on intraprostatic androgen levels in men with benign prostatic hyperplasia or prostate cancer. Urology 2008 72 : 808 812
9. Zmoff B, Strain G, Miller LK et al. Plasma free and non-sex-hormone- binding-globulin-bound testosterone are decreased in obese men in proportion to their degree of obesity. J Clin Endocrinol Metab 1993 76 : 1140 1146
10. WHO Expert Consultation. Appropriate body mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004 363 : 157 163
11. Amory JK, Anawalt BD, Matsumoto AM et al. The effect of 5alpha-reductase inhibition with dutasteride and finasteride on bone mineral density, serum lipoproteins, hemoglobin, prostate specific antigen and sexual function in healthy young men. J Urol 2008 179 : 2333 2338
12. Wurzel R, Ray P, Major-Walker K, Shannon J, Rittmaster R. The effect of dutasteride on intraprostatic dihydrotestosterone concentrations in men with benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 2007 10 : 149 154
13. Gruenewald DA, Matsumoto AM. Testosterone supplementation therapy for older men: potential benefits and risks. J Am Geriatr Soc 2003 51 : 101 115
14. Page ST, Amory JK, Bowman FD et al. Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 2005 90 : 1502 1510
15. Winters SJ, Brufsky A, Weissfeld J, Trump DL, Dyky MA, Hadeed V. Testosterone, sex hormone-binding globulin, and body composition in young adult African American and Caucasian men. Metabolism 2001 50 : 1242 1247